FYR Bio Appoints Barbara K. Zehentner as Chief Operating Officer
PRIVATEFeb 10, 2026
Position
Chief Operating Officer
Company
FYR
Barbara K. Zehentner
MissoulaBiotechnologyHealth CareArtificial IntelligenceTherapeuticsVenture Capital Fund
Description
FYR Bio has announced the appointment of Barbara K. Zehentner, MBA, PhD, HCLD (ABB), as Chief Operating Officer. In her new role, she will lead the company's operational strategy and execution as it scales its EV-Omics platform and expands collaborations.
Who to call at FYR, and when
A new leader at FYR brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day FYR raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at FYR, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at FYR. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
FYR
Location
Missoula, Montana, United States
About
FYR Bio (FYR Diagnostics Inc) is revolutionizing the ability to dynamically observe disease and treatment response to produce better biomarkers, trials, drugs and outcomes. FYR's EV-Omics™ (EVO) platform leverages its proprietary technology, SPARCs™, to enrich for extracellular vesicles from diseased cells and enable assessment of cellular proteins and nucleic acids with a peripheral blood sample. Utilizing AI-enabled multiomic insights, EVO unravels the complexity of disease mechanisms, thereby informing potential diagnostic and treatment options. The unparalleled view provided by FYR's multiomic approach can transform personalized patient care, from screening through therapy selection and monitoring.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment FYR changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.